Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/1996
04/17/1996EP0706393A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
04/17/1996EP0706386A1 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
04/17/1996EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation
04/17/1996EP0600952B1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
04/17/1996CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them
04/17/1996CN1120432A Anti inflammatory analgesic medicine and prepn. thereof
04/17/1996CN1031570C Process for preparation of pyrazolopyridine compound
04/16/1996US5508408 Leukotriene antagonists
04/16/1996US5508387 Selectin binding glycopeptides
04/16/1996US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis
04/16/1996US5508301 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
04/16/1996US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases
04/16/1996US5508290 Hindered N-oxide esters of rapamycin
04/16/1996US5508286 Rapamycin amidino carbamates
04/16/1996US5508285 Hindered N-oxide esters of rapamycin
04/16/1996US5508026 Sunscreen agents
04/11/1996WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
04/11/1996WO1996010574A1 Method for preparing concentrated biologically active silicon compounds
04/11/1996WO1996010422A1 Conjugate for treating inflammatory diseases
04/11/1996WO1996010415A1 Preparation of mhc-peptide complexes
04/11/1996WO1996010410A1 Anti-inflammatory factor, method of isolation, and use
04/11/1996WO1996005838A3 Combined preparation for the therapy of immune diseases
04/11/1996DE4436164A1 New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc.
04/11/1996CA2201519A1 Preparation of mhc-peptide complexes
04/11/1996CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them
04/11/1996CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion
04/10/1996EP0705844A1 Gene encoding cationic amino acid transporter protein
04/10/1996EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production
04/10/1996EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof
04/10/1996EP0705265A1 Novel chemical compounds having pde-iv inhibition activity
04/10/1996EP0705260A1 Condensed 4-aminopyridines with antirheumatic activity
04/10/1996EP0705258A1 Azolyl-cyclic amine derivatives with immunomodulatory activity
04/10/1996EP0705251A1 Imidazole derivatives as therapeutic agents
04/10/1996CN1120339A New prednisolone derivates
04/10/1996CN1120039A Acylated aminoalknimidazoles and-triazoles
04/09/1996US5506347 Lyxofuranosyl analogues of adenosine
04/09/1996US5506264 Antiulcer, antiinflammatory agents; reacting tranexamic acid with zinc compound and alkali agent
04/09/1996US5506249 Antiinflammatory, antiproliferative and antitumor activity
04/09/1996US5506242 Arylsufonamido-substituted hydroxamic acids
04/09/1996US5506207 GNRH antagonists XIII
04/09/1996US5506204 Muramyl compounds for treatment of septic shock
04/09/1996US5506133 Polypeptide
04/09/1996US5505715 Iontophoretic transdermal delivery of deoxyspergualin compounds
04/04/1996WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
04/04/1996WO1996010012A1 Novel prostaglandin synthase inhibitors
04/04/1996WO1996009835A1 Novel mitogen activated protein kinase, frk
04/04/1996WO1996009830A1 Composition and method for allogeneic mononuclear cell immunotherapy
04/04/1996DE4435087A1 Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen Conjugate for treatment of infectious and autoimmune diseases
04/04/1996CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use
04/04/1996CA2197657A1 Novel mitogen activated protein kinase, frk
04/03/1996EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce)
04/03/1996EP0703897A1 Lipoxin compounds
04/02/1996US5504228 From acylation of hydrolysates of silk waste; mainly-glycine, alanine and serine
04/02/1996US5504216 Method for reparing an amorphous sulfonamide
04/02/1996US5504111 Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
04/02/1996US5504108 Optically pure 4-aryl-2-hydroxytetronic acids
04/02/1996US5504107 Anticoagulants, preventing atherosclerosis
03/1996
03/31/1996CA2159257A1 Interleukin-1 production inhibiting compound
03/28/1996WO1996009310A1 Derivatives of carbohydrates and compositions containing them
03/28/1996WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin
03/28/1996WO1996009297A1 Compositions and methods for treating mast-cell inflammatory condition
03/28/1996WO1996009068A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
03/28/1996WO1996009043A1 Methods for the treatment of inflammatory joint disease
03/28/1996WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation
03/28/1996CA2200561A1 Compositions and methods for treating mast-cell inflammatory conditions
03/27/1996EP0703239A1 Aminomethylphosphonic and aminomethylphosphinic acids derivatives and their use in the treatment of degenerative articular diseases
03/27/1996EP0702678A1 Aniline derivatives
03/27/1996EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
03/27/1996EP0702554A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/27/1996EP0593506B1 Lipoaminoacids, preparation method and applications
03/27/1996EP0548250B1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
03/27/1996CN1119440A 2,6-diaminopurine derivatives
03/27/1996CN1119434A Phenoxyphenylacetic acid derivatives
03/27/1996CN1119187A oxalylamino-benzofuran- and benzothienyl-derivatives
03/26/1996US5502077 Fatty acid composition
03/26/1996US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents
03/26/1996US5502072 Substituted oxindoles
03/26/1996US5502058 Lidocaine and dextromethorphan or dextrophan
03/26/1996US5502051 Central nervous system, antispasmodic
03/26/1996US5501861 Carbohydrates
03/26/1996US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant
03/26/1996CA1338183C Cyclic peptolides
03/23/1996CA2132690A1 Control and modulation of inflammatory response in humans in need of such control and modulation
03/21/1996WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008492A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008480A1 Neurokinin antagonists
03/21/1996WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation
03/21/1996CA2200083A1 Neurokinin antagonists
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2200055A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them
03/20/1996EP0701988A1 Substituted cyclopentane-di- and triones, their preparation and their use as chloride channel blockers
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701567A1 New peptides derivatives
03/20/1996EP0701565A1 New prednisolone derivates
03/20/1996EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/20/1996EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 1272